Back to Health

What Is Atazanavir and What Is It For?

What Is Atazanavir and What Is It For?
Bareback Guide 12 March 2026

Atazanavir is a protease inhibitor used in combination HIV treatment. It requires a booster to work at a practical dose, and it produces a distinctive and harmless side effect that causes a good deal of unnecessary alarm.

What kind of drug is it?

A protease inhibitor, a class that transformed HIV treatment in the mid-1990s. These act at a later stage of the viral life cycle than the nucleoside analogues, targeting the assembly of new virus rather than the copying of its genome.

How does it work?

HIV manufactures its proteins as long chains that have to be cut into functional pieces before a new particle can mature. The enzyme that does the cutting is called protease. Atazanavir binds to it and blocks it.

What happens then?

New virus particles are still produced, and they are immature and non-infectious. The proteins inside remain as uncut chains and cannot assemble into a working virus, so the infection cannot spread to further cells.

Why does it need a booster?

Because the liver clears it quickly enough that unrealistic doses would be needed. A booster, either ritonavir or cobicistat, blocks the enzyme responsible, allowing a single daily dose to maintain useful levels. The booster has no antiviral effect of its own.

What is it used for?

HIV treatment as part of a combination. It is no longer a first-line choice in most UK guidance, having been overtaken by integrase inhibitors, and it remains in use for people who have done well on it for years and where other options are limited.

What is its main advantage?

A high barrier to resistance, typical of boosted protease inhibitors. Resistance to it develops slowly and rarely, which makes it useful where adherence is unpredictable or where resistance to other classes already exists.

Why the yellow eyes?

Atazanavir interferes with the enzyme that processes bilirubin, so bilirubin levels rise and the whites of the eyes can yellow. It is not liver damage and it causes no harm. It is visible, which is a legitimate reason some people prefer something else.

What is the main drawback?

Its dependence on stomach acid for absorption, which creates a significant interaction with acid-reducing medication, and the extensive interaction profile that comes with any booster.

How does it compare with darunavir?

Darunavir has a higher resistance barrier and no jaundice, and it is generally preferred where a protease inhibitor is wanted. Atazanavir has a somewhat different tolerability profile and remains a reasonable option for some people.

Is it available generically?

Yes, both on its own and in some combination products, which has reduced cost considerably.

Where does it sit against the alternatives?

No antiretroviral is best in every situation. The fit depends on your resistance history, your other medicines, whether you take acid-reducing drugs and how you feel about the jaundice. That is a conversation with a clinician rather than a ranking.

How long has it been available?

Since the early 2000s, so there is over twenty years of clinical experience. Its properties are thoroughly characterised, which is one reason it remains useful even though it is not usually chosen first.

What does it not do?

It treats HIV only. It has no activity against hepatitis B, no effect on any sexually transmitted infection and no preventive role. Regular screening remains necessary regardless of what you take.

Is it a lifelong medicine?

HIV treatment is taken indefinitely rather than for a course, because stopping allows the virus to rebound within weeks. What people take does change over the years, as better options appear and as circumstances shift, so being on atazanavir now does not mean being on it forever.

Does it work if you take it properly?

For the great majority of people, yes. Modern combinations containing atazanavir achieve an undetectable viral load in most people who take them consistently, and once suppression is sustained, HIV is not passed on sexually.

Who chooses your regimen?

A clinician, with you. The clinical constraints are fixed and within them your preferences are legitimate: tablet size, dosing schedule, side effects you would rather not have, and how a regimen fits the way you actually live.